Dr. JoAnn V. Pinkerton MD
JoAnn Pinkerton is a Professor of Obstetrics and Gynecology and Division Director of Midlife Health Center at the University of Virginia Health System in Charlottesville, Virginia, Executive Director of North American Menopause Society (NAMS) since October 2015 and became President of South Atlantic Association of Obstetrics and Gynecology SAAOG in 2016. She is a certified Menopause Specialist, a longtime fellow of ACOG, 2008-09 President of NAMS and as served on many national and international committees and local University of Virginia Committees. Awards include the 2013 UVA Sharon Hostler Women in Leadership award, BEST DOCTORs and TOP DOCTORS in America since 2010. She won an American Library Association Award for her book, Understanding Midlife Health. She is the Associate Editor for the Journal Menopause and the section director for menopause for the Journal of Women’s Health. She serves on the Editorial Boards for Menopause and Climacteric. She has published more than 100 peer-reviewed publications, 30 invited papers and 11 invited chapters and served as PI for over 30 clinical trials on treatment of hot flashes with hormonal and non-hormonal therapies. She is a strong proponent of education at the national level as well as within the community, holding Midlife Community Educational Symposiums-two per year to allow tailored education appropriate for different backgrounds.
She is married and the mother of three children, Jeremy, (deceased 2010 MVA), Katie, who is married and has a Masters in graphic design, and Liz, who is a second year medical student at Wake forest. She provides medical safety for the Women’s 4 mile Breast Cancer Training Program, runs herself, and plays mandolin.
I have/had an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization:
- I am a member of an Advisory Board or equivalent with a commercial organization: Pfizer
- I have received payment from a commercial organization (including gifts or other consideration or ‘in kind’ compensation): Pfizer, Shionogi, Therapeutics MD
- I am currently participating in or have participated in a clinical trial within the past two years: Therapeutics MD
I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).